These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7980868

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
    Xu B, Hu SQ, Chu YC, Huang K, Nakagawa SH, Whittaker J, Katsoyannis PG, Weiss MA.
    Biochemistry; 2004 Jul 06; 43(26):8356-72. PubMed ID: 15222748
    [Abstract] [Full Text] [Related]

  • 23. Comparison of reaction rates in trypsin-catalysed transamidation of porcine insulin and its B29-arginine analogue.
    Cao QP, Zhang YS, Geiger R.
    Biol Chem Hoppe Seyler; 1988 Apr 06; 369(4):283-7. PubMed ID: 3041989
    [Abstract] [Full Text] [Related]

  • 24. Analog binding properties of insulin receptor mutants. Identification of amino acids interacting with the COOH terminus of the B-chain of the insulin molecule.
    Mynarcik DC, Williams PF, Schaffer L, Yu GQ, Whittaker J.
    J Biol Chem; 1997 Jan 24; 272(4):2077-81. PubMed ID: 8999905
    [Abstract] [Full Text] [Related]

  • 25. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
    Stümpel F, Hartmann H, Brandenburg D, Creutzfeldt W.
    Diabetes Res Clin Pract; 1990 Jul 24; 9(3):257-64. PubMed ID: 2226126
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Structure-activity relationship of covalently dimerized insulin derivatives: correlation of partial agonist efficacy with cross-linkage at lysine B29.
    Deppe C, Breiner M, Brandenburg D, Joost HG.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug 24; 350(2):213-7. PubMed ID: 7990980
    [Abstract] [Full Text] [Related]

  • 28. Preparation of [B23-D-alanine]des-(B25-B30)-hexapeptide-insulin by a combination of enzymic and non-enzymic synthesis.
    Zhang YS, Cao QP, Li ZG, Cui DF.
    Biochem J; 1983 Dec 01; 215(3):697-9. PubMed ID: 6362662
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain.
    Nakagawa SH, Tager HS.
    J Biol Chem; 1987 Sep 05; 262(25):12054-8. PubMed ID: 3305501
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
    Mirmira RG, Tager HS.
    Biochemistry; 1991 Aug 20; 30(33):8222-9. PubMed ID: 1868095
    [Abstract] [Full Text] [Related]

  • 35. Importance of main-chain flexibility and the insulin fold in insulin-receptor interactions.
    Nakagawa SH, Tager HS.
    Biochemistry; 1993 Jul 20; 32(28):7237-43. PubMed ID: 8343513
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.